AAAAAA
Results:
1-21
|
Results: 21
Authors:
BISHOP JF
MATTHEWS JP
YOUNG GAR
BRADSTOCK K
LOWENTHAL RM
Citation: Jf. Bishop et al., INTENSIFIED INDUCTION CHEMOTHERAPY WITH HIGH-DOSE CYTARABINE AND ETOPOSIDE FOR ACUTE MYELOID-LEUKEMIA - A REVIEW AND UPDATED RESULTS OF THEAUSTRALIAN-LEUKEMIA-STUDY-GROUP, Leukemia & lymphoma, 28(3-4), 1998, pp. 315-327
Authors:
LOWENTHAL RM
FABERES C
MARIT G
BOIRON JM
CONYMAKHOUL P
PIGNEUX A
AGAPE P
VEZON G
BOUZGAROU R
DAZEY B
FIZET D
BERNARD P
LACOMBE F
REIFFERS J
Citation: Rm. Lowenthal et al., FACTORS INFLUENCING HEMATOPOIETIC RECOVERY FOLLOWING CHEMOTHERAPY-MOBILIZED AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FORHEMATOLOGICAL MALIGNANCIES - A RETROSPECTIVE ANALYSIS OF A 10-YEAR SINGLE INSTITUTION EXPERIENCE, Bone marrow transplantation, 22(8), 1998, pp. 763-770
Authors:
LOWENTHAL RM
MARSDEN KA
Citation: Rm. Lowenthal et Ka. Marsden, MYELODYSPLASTIC SYNDROMES, International journal of hematology, 65(4), 1997, pp. 319-338
Authors:
LOWENTHAL RM
BARNETT VL
Citation: Rm. Lowenthal et Vl. Barnett, NEUTROPENIA ALERT CARDS, Medical journal of Australia, 167(3), 1997, pp. 176-176
Authors:
LOWENTHAL RM
OMALLEY S
ARTHUR GE
Citation: Rm. Lowenthal et al., HOME CHEMOTHERAPY FOR CANCER-PATIENTS - COST-ANALYSIS AND SAFETY - REPLY, Medical journal of Australia, 166(2), 1997, pp. 110-110
Authors:
BOIRON JM
REIFFERS J
LOWENTHAL RM
Citation: Jm. Boiron et al., BLOOD-CELL TRANSPLANTATION - PAST, PRESENT AND FUTURE, HEM CELL TH, 38(5), 1996, pp. 399-407
Authors:
LOWENTHAL RM
EATON K
Citation: Rm. Lowenthal et K. Eaton, TOXICITY OF CHEMOTHERAPY, Hematology/oncology clinics of North America, 10(4), 1996, pp. 967
Authors:
MESCH U
LOWENTHAL RM
COLEMAN D
Citation: U. Mesch et al., LEAD-POISONING MASQUERADING AS CHRONIC FATIGUE SYNDROME, Lancet, 347(9009), 1996, pp. 1193-1193
Authors:
LOWENTHAL RM
SULLIVAN SA
PARKER N
MARSDEN KA
Citation: Rm. Lowenthal et al., G-CSF-PRIMED BONE-MARROW CELLS FOR AUTOLOGOUS TRANSPLANTATION, Lancet, 347(9008), 1996, pp. 1125-1125
Authors:
LOWENTHAL RM
PIASZCZYK A
ARTHUR GE
OMALLEY S
Citation: Rm. Lowenthal et al., HOME CHEMOTHERAPY FOR CANCER-PATIENTS - COST-ANALYSIS AND SAFETY, Medical journal of Australia, 165(4), 1996, pp. 184-187
Authors:
LOWENTHAL RM
Citation: Rm. Lowenthal, ALTERNATIVE CANCER TREATMENTS, Medical journal of Australia, 165(10), 1996, pp. 536-537
Authors:
LOWENTHAL RM
LUCK JC
CLENNETT D
SULLIVAN SA
PARKER N
MARSDEN KA
Citation: Rm. Lowenthal et al., HEMATOPOIETIC STEM-CELLS REMAIN VIABLE AFTER CRYOPRESERVATION FOR UP TO 16 YEARS, Blood, 88(10), 1996, pp. 3679-3679
Authors:
BISHOP JF
MATTHEWS JP
YOUNG GA
SZER J
GILLETT A
JOSHUA D
BRADSTOCK K
ENNO A
WOLF MM
FOX R
COBCROFT R
HERRMANN R
VANDERWEYDEN M
LOWENTHAL RM
PAGE F
GARSON OM
JUNEJA S
Citation: Jf. Bishop et al., A RANDOMIZED STUDY OF HIGH-DOSE CYTARABINE IN INDUCTION IN ACUTE MYELOID-LEUKEMIA, Blood, 87(5), 1996, pp. 1710-1717
Authors:
LOWENTHAL RM
BRADSTOCK KM
MATTHEWS JP
ENNO A
GILL D
PAGE FJ
ROONEY KF
TAYLOR KM
Citation: Rm. Lowenthal et al., IDARUBICIN, CYTARABINE IN STANDARD OR HIGH-DOSE, AND ETOPOSIDE + - LENOGRASTIM (G-CSF) FOR ADULT ACUTE MYELOID-LEUKEMIA (AML) - COMBINATIONS GIVING HIGH REMISSION RATES/, Blood, 86(10), 1995, pp. 3059-3059
Authors:
LOWENTHAL RM
SULLIVAN SA
MARSDEN KA
PARKER N
Citation: Rm. Lowenthal et al., G-CSF-STIMULATED BONE-MARROW (BM) HARVESTS TO OBTAIN SUFFICIENT STEM-CELLS FOR AUTOLOGOUS TRANSPLANTATION FROM EXTENSIVELY PRETREATED PATIENTS, Blood, 86(10), 1995, pp. 3936-3936
RANDOMIZED COMPARISON OF MACOP-B WITH CHOP IN PATIENTS WITH INTERMEDIATE-GRADE NON-HODGKINS-LYMPHOMA
Authors:
COOPER IA
WOLF MM
ROBERTSON TI
FOX RM
MATTHEWS JP
STONE JM
DING JC
DART G
MATTHEWS J
FIRKIN FC
LOWENTHAL RM
IRONSIDE P
Citation: Ia. Cooper et al., RANDOMIZED COMPARISON OF MACOP-B WITH CHOP IN PATIENTS WITH INTERMEDIATE-GRADE NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 12(4), 1994, pp. 769-778
Authors:
LOWENTHAL RM
Citation: Rm. Lowenthal, ON EYE OF NEWT AND BONE OF SHARK - THE DANGERS OF PROMOTING ALTERNATIVE CANCER TREATMENTS, Medical journal of Australia, 160(6), 1994, pp. 323-324
Authors:
THOMSON DB
ADENA M
MCLEOD GRC
HERSEY P
GILL PG
COATES AS
OLVER IN
KEFFORD RF
LOWENTHAL RM
BEADLE GF
WALPOLE ET
BOLAND K
KINGSTON D
Citation: Db. Thomson et al., INTERFERON-ALPHA-2A DOES NOT IMPROVE RESPONSE OR SURVIVAL WHEN COMBINED WITH DACARBAZINE IN METASTATIC MALIGNANT-MELANOMA - RESULTS OF A MULTIINSTITUTIONAL AUSTRALIAN RANDOMIZED TRIAL, Melanoma research, 3(2), 1993, pp. 133-138
Authors:
COATES A
THOMSON D
MCLEOD GRM
HERSEY P
GILL PG
OLVER IN
KEFFORD R
LOWENTHAL RM
BEADLE G
WALPOLE E
Citation: A. Coates et al., PROGNOSTIC VALUE OF QUALITY-OF-LIFE SCORES IN A TRIAL OF CHEMOTHERAPYWITH OR WITHOUT INTERFERON IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA, European journal of cancer, 29A(12), 1993, pp. 1731-1734
Authors:
LOWENTHAL RM
CHALLIS DR
GRIFFITHS AE
CHAPPELL RA
GOULDER PJR
Citation: Rm. Lowenthal et al., TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE - REPORT OF AN OCCURRENCE FOLLOWING THE ADMINISTRATION OF IRRADIATED BLOOD, Transfusion, 33(6), 1993, pp. 524-529
Authors:
LOWENTHAL RM
MATTHEWS JP
BISHOP JF
BUNCE IH
COBCROFT RG
ELIADIS P
HARVEY MP
HERMANN RP
JANUSZEWICZ EH
KIMBER RI
LINDEMAN R
MANOHARAN A
PAGE FJ
ROONEY KF
ROSENFELD D
TAYLOR KM
WILEY JS
WOLF MM
YOUNG GAR
Citation: Rm. Lowenthal et al., IDARUBICIN, CYTOSINE-ARABINOSIDE IN STANDARD OR HIGH-DOSE, AND ETOPOSIDE - COMBINATIONS GIVING HIGH REMISSION RATES IN ADULT ACUTE MYELOID-LEUKEMIA (AML) - PILOT-STUDIES OF THE AUSTRALIAN LEUKEMIA STUDY-GROUP (ALSG), Blood, 82(10), 1993, pp. 10000328-10000328
Risultati:
1-21
|